Specifically, in HNSCC, PSMG2 is significantly overexpressed in tumor tissue, with its expression increasing as the tumor stage progresses and correlating with poorer overall survival, suggesting its potential oncogenic role. The gene discussed is PSMG2; the disease is head and neck squamous cell carcinoma.